Part 2 Capital Fees for Pre-Application MeetingsF1
Repealed
- 3Interpretation of Part 2
- 4Fee for scientific advice: application for, or variation to, EU marketing authorization
- 5Fee for scientific advice: classification of a medicinal product
- 6Fee for advertising advice
- 7Fee for pharmacovigilance advice
- 8Fee for advice on labelling or leaflets
- 9Fee for regulatory advice
- 10Fee for advice for other purposes
- 11Time for payment of fees under regulations 4 to 10
Annotations
Textual amendments
- F1
Regulations revoked (1.4.2013) by The Medicines (Products for Human Use) (Fees) Regulations 2013 (S.I. 2013/532), reg. 59(1) (with reg. 59(2)-(4))